[ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] DESCRIPTION CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) is a mydriatic prepared as a sterile topical ophthalmic solution .
The active ingredients are represented by the chemical structures : [ MULTIMEDIA ] Established Name : Cyclopentolate Hydrochloride Chemical Name : 2 - ( Dimethylamino ) ethyl 1 - hydroxy - α - phenylcyclopentaneacetate hydrochloride ) Molecular Formula : Molecular Weight : [ MULTIMEDIA ] Established Name : Phenylephrine Hydrochloride Chemical Name : 3 - hydroxy - α [ ( methylamino ) - methyl ] - , Benzenemethanol , hydrochloride ( R ) - .
Molecular Formula : Molecular Weight : Each mL of CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) contains : Active : cyclopentolate hydrochloride 0 . 2 % , phenylephrine hydrochloride 1 % .
Preservative : benzalkonium chloride 0 . 01 % .
Inactives : edetate disodium , boric acid , hydrochloric acid and / or sodium carbonate ( to adjust pH ) , purified water .
[ MULTIMEDIA ] [ MULTIMEDIA ] CLINICAL PHARMACOLOGY Cyclopentolate hydrochloride is an anticholinergic drug and phenylephrine hydrochloride is an adrenergic drug .
This combination induces mydriasis that is greater than that of either drug alone at its respective concentration .
The concentrations of cyclopentolate hydrochloride and phenylephrine hydrochloride have been selected to induce mydriasis with little accompanying cycloplegia .
Heavily pigmented irides may require more doses than lightly pigmented irides .
INDICATIONS AND USAGE For the production of mydriasis .
CONTRAINDICATIONS Do not use in patients with untreated narrow - angle glaucoma or with untreated anatomically narrow angles or where there is hypersensitivity to any component of this preparation .
WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY .
NOT FOR INJECTION .
The use of this combination may have an adverse effect on individuals suffering from cardiovascular disease , hypertension , and hyperthyroidism , and it may cause CNS disturbances .
Infants are especially prone to CNS and cardiopulmonary side effects from cyclopentolate .
Observe infants closely for at least 30 minutes .
Mydriatics may produce a transient elevation of intraocular pressure .
PRECAUTIONS General The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption .
Caution should be observed when considering use of this medication in the presence of Down ' s syndrome and in those predisposed to angle - closure glaucoma .
The effect of long - term use of this preparation has not been established , therefore , it should be restricted to short - term use .
Information for Patients Do not touch dropper tip to any surface , as this may contaminate the solution .
Patient should be advised not to drive or engage in hazardous activities while pupils are dilated .
Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation .
Parents should be warned not to get this preparation in their child ' s mouth and to wash their own hands and the child ' s hands following administration .
Feeding intolerance may follow ophthalmic use of this product in infants .
It is recommended that feeding be withheld for four ( 4 ) hours after examination .
Drug Interactions Cyclopentolate may interfere with the ocular anti - hypertensive action of carbachol , pilocarpine , or ophthalmic cholinesterase inhibitors .
Carcinogenesis , Mutagenesis , Impairment of Fertility There have been no long - term studies done using cyclopentolate hydrochloride and / or phenylephrine hydrochloride in animals to evaluate carcinogenic potential .
Pregnancy Animal reproduction studies have not been conducted with cyclopentolate hydrochloride and / or phenylephrine hydrochloride .
It is also not known whether cyclopentolate hydrochloride and / or phenylephrine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity .
CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) should be given to a pregnant woman only if clearly needed .
Nursing Mothers It is not known whether these drugs are excreted in human milk .
Because many drugs are excreted in human milk , caution should be exercised when CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) is administered to a nursing woman .
Pediatric Use Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances in pediatric patients .
Increased susceptibility to cyclopentolate has been reported in infants , young children , and in children with spastic paralysis or brain damage .
These disturbances include ataxia , incoherent speech , restlessness , hallucinations , hyperactivity , seizures , disorientation as to time and place , and failure to recognize people .
Feeding intolerance may follow ophthalmic use of this product in infants .
It is recommended that feeding be withheld for 4 hours after examination .
Observe infants closely for at least 30 minutes ( see PRECAUTIONS ) .
Geriatric Use No overall differences in safety or effectiveness have been observed between elderly and younger patients .
ADVERSE REACTIONS Ocular The following ocular adverse experiences have been associated with the use of CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) : increased intraocular pressure , burning / irritation upon instillation , photophobia , blurred vision and superficial punctate keratitis .
Nonocular Use of cyclopentolate hydrochloride has been associated with psychotic reactions and behavioral disturbances in children .
These disturbances include ataxia , incoherent speech , restlessness , hallucinations , hyperactivity , seizures , disorientation as to time and place , and failure to recognize people .
This drug produces reactions similar to those of other adrenergic and anticholinergic drugs ; however , the central nervous system manifestations as noted above are most common .
Other manifestations of adrenergic and anticholinergic topical ophthalmic drugs include tachycardia , hyperpyrexia , hypertension , vasodilation , urinary retention , diminished gastrointestinal motility , and decreased secretion in salivary and sweat glands , pharynx , bronchi and nasal passages .
Severe manifestations of toxicity include coma , medullary paralysis and death .
OVERDOSAGE Excessive dosage may produce behavioral disturbances , tachycardia , hyperpyrexia , hypertension , elevated intraocular pressure , vasodilation , urinary retention , diminished gastrointestinal motility and decreased secretion in salivary and sweat glands , pharynx , bronchi and nasal passages .
Patients exhibiting signs of overdosage should receive supportive care and monitoring .
DOSAGE AND ADMINISTRATION Instill one drop in each eye every five to ten minutes .
To minimize systemic absorption , apply pressure over the nasolacrimal sac for two to three minutes following instillation .
Observe infants closely for at least 30 minutes .
HOW SUPPLIED CYCLOMYDRIL ® ( cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution ) is supplied as a sterile solution in 2 mL and 5 mL , in plastic DROP - TAINER ® dispensers .
2 mL NDC 0065 - 0359 - 02 5 mL NDC 0065 - 0359 - 05 Storage : Store at 8 ° C to 25 ° C ( 46 ° F - 77 ° F ) Distributed by : ALCON LABORATORIES , INC .
6201 South Freeway Fort Worth , Texas 76134 - 2099 © 2004 , 2013 , 2018 , 2021 Alcon Inc .
T2018 - 97 Revised : June 2018 PRINCIPAL DISPLAY PANEL NDC 0065 - 0359 - 05 Alcon Cyclomydril ® ( cyclopentolate hydrochloride , phenylephrine hydrochloride ophthalmic solution ) 5 mL Sterile Rx Only Sterile Ophthalmic Solution USUAL DOSAGE : Instill one drop in each eye every five to ten minutes .
Read enclosed insert .
FOR TOPICAL OPHTHALMIC USE ONLY WARNING : Do not touch dropper tip to any surface as this may contaminate the solution .
INGREDIENTS : Each mL contains : Active : cyclopentolate hydrochloride 0 . 2 % , phenylephrine hydrochloride 1 % .
Preservative : benzalkonium chloride 0 . 01 % .
Inactives : edetate disodium , boric acid , hydrochloric acid and / or sodium carbonate ( to adjust pH ) , purified water .
STORAGE : Store at 8 ° - 25 ° C ( 46 ° to 77 ° F ) .
Alcon ALCON LABORATORIES , INC .
Fort Worth , Texas 76134 USA Printed in USA SN : LOT : EXP . : GTIN : 00300650359054 300048632 - 0821 [ MULTIMEDIA ] NDC 0065 - 0359 - 05 Alcon Cyclomydril ® ( cyclopentolate hydrochloride , phenylephrine hydrochloride ophthalmic solution ) 5 mL Sterile Rx Only Sterile Ophthalmic Solution USUAL DOSAGE : Instill one drop in each eye every five to ten minutes .
Read enclosed insert .
FOR TOPICAL OPHTHALMIC USE ONLY WARNING : Do not touch dropper tip to any surface as this may contaminate the solution .
INGREDIENTS : Each mL contains : Active : cyclopentolate hydrochloride 0 . 2 % , phenylephrine hydrochloride 1 % .
Preservative : benzalkonium chloride 0 . 01 % .
Inactives : edetate disodium , boric acid , hydrochloric acid and / or sodium carbonate ( to adjust pH ) , purified water .
STORAGE : Store at 8 ° - 25 ° C ( 46 ° to 77 ° F ) .
© 2004 , 2010 , 2013 Novartis 9014758 US Alcon ® a Novartis company ALCON LABORATORIES , INC .
Fort Worth , Texas 76134 USA Printed in USA LOT : EXP . : [ MULTIMEDIA ] NDC 0065 - 0359 - 05 Alcon Cyclomydril ® ( cyclopentolate hydrochloride , phenylephrine hydrochloride ophthalmic solution ) Sterile 5 mL Rx Only INGREDIENTS : Each mL contains : Actives : cyclopentolate hydrochloride 0 . 2 % , phenylephrine hydrochloride 1 % .
Preservative : benzalkonium chloride 0 . 01 % .
Inactives : edetate disodium , boric acid , hydrochloric acid and / or sodium carbonate ( to adjust pH ) , purified water .
WARNING : Do not touch dropper tip to any surface as this may contaminate the solution .
USUAL DOSAGE : Instill one drop in each eye every five to ten minutes .
Read enclosed insert .
STORAGE : Store at 8 ° - 25 ° C ( 46 ° to 77 ° F ) .
Printed in USA ALCON LABORATORIES , INC .
Fort Worth , Texas 76134 USA LOT : EXP . : 300048631 - 0821 [ MULTIMEDIA ] NDC 0065 - 0359 - 05 Alcon Cyclomydril ® ( cyclopentolate hydrochloride , phenylephrine hydrochloride ophthalmic solution ) Sterile 5 mL Rx Only INGREDIENTS : Each mL contains : Actives : cyclopentolate hydrochloride 0 . 2 % , phenylephrine hydrochloride 1 % .
Preservative : benzalkonium chloride 0 . 01 % .
Inactives : edetate disodium , boric acid , hydrochloric acid and / or sodium carbonate ( to adjust pH ) , purified water .
WARNING : Do not touch dropper tip to any surface , as this may contaminate the solution .
USUAL DOSAGE : Instill one drop in each eye every five to ten minutes .
Read enclosed insert .
STORAGE : Store at 8 ° - 25 ° C ( 46 ° - 77 ° F ) .
Printed in USA © 2004 , 2013 Novartis ALCON LABORATORIES , INC .
Fort Worth , Texas 76134 USA LOT : EXP . : H14882 US [ MULTIMEDIA ]
